Lombard Odier Asset Management (Switzerland)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,700
Closed -$240K 369
2019
Q4
$240K Hold
3,700
0.02% 334
2019
Q3
$235K Hold
3,700
0.03% 323
2019
Q2
$250K Hold
3,700
0.03% 303
2019
Q1
$241K Buy
+3,700
New +$246K 0.02% 329

Other funds holding GILD

Lombard Odier Asset Management (Switzerland)'s GILD Position: Q1 2026 in Review

Lombard Odier Asset Management (Switzerland) increased its Gilead Sciences (GILD) stake by 7.1% in Q1 2026, buying an estimated $532K and bringing the position to 57,445 shares worth $8.01M. The position accounts for 0.3% of the portfolio, ranked #75.

Lombard Odier Asset Management (Switzerland) first reported a position in GILD in Q2 2014 and has held it in 44 quarters since. The position peaked at $36.1M in Q3 2014. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lombard Odier Asset Management (Switzerland) held 57,445 shares of Gilead Sciences worth $8.01M as of Q1 2026.
  • Lombard Odier Asset Management (Switzerland) bought 3,801 Gilead Sciences shares in Q1 2026, an estimated $532K.
  • Gilead Sciences made up 0.3% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #75 holding.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Gilead Sciences in Q2 2014 and has held it in 44 quarters since.
  • Lombard Odier Asset Management (Switzerland)'s Gilead Sciences position peaked at $36.1M in Q3 2014.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.